Connect Biopharma Holdings L logo

CNTB

Connect Biopharma Holdings L

$0.75

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Connect Biopharma Holdings L post its latest quarter earnings

EPS Estimate Current Year
-5.28

Highlights

EPS Estimate Current Year:

Connect Biopharma Holdings L’s earning per share (EPS) estimates for the current year stand at -5.28.

Key Ratios

Key ratios of the Connect Biopharma Holdings L post its Q1 2023 earnings

Return on Assets (ROA)
-0.32
Return on Equity (ROE)
-0.56

Highlights

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Connect Biopharma Holdings L’s return on assets (ROA) stands at -0.32.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Connect Biopharma Holdings L’s return on equity (ROE) stands at -0.56.